Search

Your search keyword '"St Laurent Denis R"' showing total 38 results

Search Constraints

Start Over You searched for: Author "St Laurent Denis R" Remove constraint Author: "St Laurent Denis R"
38 results on '"St Laurent Denis R"'

Search Results

2. HCV NS5A replication complex inhibitors. Part 3 : discovery of potent analogs with distinct core topologies

3. HCV NS5A replication complex inhibitors. Part 2: Investigation of stilbene prolinamides

4. Hepatitis C Virus NS5A Replication Complex Inhibitors: The Discovery of Daclatasvir

5. Discovery and Development of Hepatitis C Virus NS5A Replication Complex Inhibitors

6. Hepatitis C Virus NS5A Replication Complex Inhibitors. Part 6: Discovery of a Novel and Highly Potent Biarylimidazole Chemotype with Inhibitory Activity Toward Genotypes 1a and 1b Replicons

7. HCV NS5A Replication Complex Inhibitors. Part 4.1 Optimization for Genotype 1a Replicon Inhibitory Activity

8. Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical Stilbenes

10. Identification of Hepatitis C Virus NS5A Inhibitors

12. Novel 3‘,6‘-Anhydro and N12,N13-Bridged Glycosylated Fluoroindolo[2,3-a]carbazoles as Topoisomerase I Inhibitors. Fluorine as a Leaving Group from sp3Carbon

13. Discovery of a Fluoroindolo[2,3-a]carbazole Clinical Candidate with Broad Spectrum Antitumor Activity in Preclinical Tumor Models Superior to the Marketed Oncology Drug, CPT-11

14. Design and Synthesis of a Fluoroindolocarbazole Series as Selective Topoisomerase I Active Agents. Discovery of Water-Soluble 3,9-Difluoro-12,13-dihydro-13-[6-amino-β-d-glucopyranosyl]-5H,13H-benzo[b]thienyl[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (BMS-251873) with Curative Antitumor Activity against Prostate Carcinoma Xenograft Tumor Model.

15. Design and Synthesis of a Fluoroindolocarbazole Series as Selective Topoisomerase I Active Agents. Discovery of Water-Soluble 3,9-Difluoro-12,13-dihydro-13-[6-amino-β- d-glucopyranosyl]-5H,13H-benzo[b]- thienyl[2,3-a]pyrrolo[3,4-c]carbazole- 5,7(6H)-dione (BMS-251873) with Curative Antitumor Activity against Prostate Carcinoma Xenograft Tumor Model

17. Sordarin Oxazepine Derivatives as Potent Antifungal Agents

23. HCV NS5AReplication Complex Inhibitors. Part 4.1 Optimization for Genotype 1a Replicon InhibitoryActivity.

25. Hepatitis C Virus NS5A ReplicationComplex Inhibitors.Part 6: Discovery of a Novel and Highly Potent Biarylimidazole Chemotypewith Inhibitory Activity Toward Genotypes 1a and 1b Replicons.

27. Total synthesis of the Lycopodium alkaloids magellanine and magellaninone by three-fold...

28. Hepatitis C Virus Inhibitors

29. Hepatitis C Virus Inhibitors

30. Hepatitis C Virus Inhibitors

31. Hepatitis C Virus Inhibitors

32. Hepatitis C Virus Inhibitors

33. Hepatitis C Virus Inhibitors

34. Hepatitis C Virus Inhibitors

37. HCV NS5A replication complex inhibitors. Part 31: discovery of potent analogs with distinct core topologies

38. Design and synthesis of a fluoroindolocarbazole series as selective topoisomerase I active agents. Discovery of water-soluble 3,9-difluoro-12,13-dihydro-13-[6-amino-beta-D-glucopyranosyl]-5H,13H-benzo[b]- thienyl[2,3-a]pyrrolo[3,4-c]carbazole- 5,7(6H)-dione (BMS-251873) with curative antitumor activity against prostate carcinoma xenograft tumor model.

Catalog

Books, media, physical & digital resources